Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01692938 · ClinicalTrials.gov registry record
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
A clinical trial of Age-related Macular Degeneration and Diabetic Retinopathy, sponsored by Optos.
- Completed
- Registry status
- 32
- Enrollment target
- 3
- Study locations
NCT01692938: Completed study of Age-related Macular Degeneration and Diabetic Retinopathy, sponsored by Optos.
NCT01692938 is a study of Age-related Macular Degeneration and Diabetic Retinopathy that has completed, run by Optos. The registered enrollment target is 32 participants, below the 1,507-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01692938, a study of Age-related Macular Degeneration and Diabetic Retinopathy, has completed, sponsored by Optos.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
- 3
- Study locations
Study Summary
To conduct a precision study to assess the microperimetry function of the Spectral OCT/SLO. The study will assess variability across measurements taken by three different operator-device configuration across clinical sites, variability between subjects within a given operator-device configuration, and variability within a subject for a single operator-device configuration.
Primary Outcome
A precision study was conducted that used 3 devices (each with a different operator). Each device was used to measure 4 normal subjects and 4 subjects with relevant eye pathology, with a total of 24 subject eyes (12 normal, 12 with pathology) measured across all three devices. For each subject, one eye was evaluated using 3 tests with repositioning at the start of each test. Test results were given in decibels which is the unit used in microperimetry testing. Overall mean and standard deviation
Conditions Studied
Study Locations (3)
Florida
- Retina Group of Florida - Fort Lauderdale
Maryland
- Johns Hopkins Unversity - Baltimore
Texas
- Valley Retina Institute - McAllen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2012-10 |
| Est. Completion | 2012-11 |
What the finished NCT01692938 record still lists
NCT01692938 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,507-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (98% lower).
The record links to 9 conditions, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 0 interventions.
NCT01692938 reports a single indexed study location in Florida, Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT01692938 about?
NCT01692938 is a clinical study titled "Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO". To conduct a precision study to assess the microperimetry function of the Spectral OCT/SLO. The study will assess variability across measurements taken by three different operator-device configuration across clinical sites, variability between subjects within a given operator-device configuration, a...
What is the current status of trial NCT01692938?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2012-10. Estimated completion is 2012-11.
What conditions does trial NCT01692938 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration, Diabetic Retinopathy, Geographic Atrophy, Macular Edema, Retinal Vein Occlusion.
Who is sponsoring clinical trial NCT01692938?
This trial is sponsored by Optos, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01692938 being conducted?
This trial has 3 study locations across Florida, Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01692938's enrollment target sits among peer trials
32 57th of 74 higher than 18 of 74 other Age-related Macular Degeneration trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Age-related Macular Degeneration trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
RECRUITING · Phase 2
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
High Resolution Retinal Imaging
RECRUITING
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RECRUITING · Phase 1
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia